James A. Bianco

CIK: 0001198554

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HURA

TuHURA Biosciences, Inc./NV

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

HURA
TuHURA Biosciences, Inc./NV
May 28, 2026
Gift(G)
Direct
150K shares-
HURA
TuHURA Biosciences, Inc./NV
Jan 6, 2026
Award(A)
Options (Right to Buy)
Direct
610.3K shares-
HURA
TuHURA Biosciences, Inc./NV
Dec 12, 2025
Award(A)
Options (Right to Buy)
Direct
3.4M shares-
HURA
TuHURA Biosciences, Inc./NV
Nov 12, 2024
Award(A)
Options (Right to Buy)
Direct
1.1M shares-
KTRA
Kintara Therapeutics, Inc.
Oct 18, 2024
Award(A)
Direct
2.3M shares-

		Type	Shares	Price		Ownership
May 28, 2026	HURA TuHURA Biosciences, Inc./NV	Gift(G)	150,000	-	$0	Direct
Jan 6, 2026	HURA TuHURA Biosciences, Inc./NV	Award(A) Options (Right to Buy)	610,332	-	-	Direct
Dec 12, 2025	HURA TuHURA Biosciences, Inc./NV	Award(A) Options (Right to Buy)	3,414,891	-	-	Direct
Nov 12, 2024	HURA TuHURA Biosciences, Inc./NV	Award(A) Options (Right to Buy)	1,065,990	-	-	Direct
Oct 18, 2024	KTRA Kintara Therapeutics, Inc.	Award(A)	2,323,307	-	$0	Direct

1-5 of 5 transactions

About Bianco James A.

Bianco James A. (SEC CIK 0001198554) files insider reports with the SEC as Chief Executive Officer of TuHURA Biosciences, Inc./NV (HURA).

Signal8 holds 6 ownership filings by Bianco James A. (1 Form 3, 5 Form 4), filed between Oct 22, 2024 and May 29, 2026. Those filings report 5 transactions, from Oct 18, 2024 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bianco James A.'s filings is in TAMPA, FL.

Recent filings by Bianco James A.

May 28, 2026: Gift of HURA shares (Form 4, code G).
Jan 6, 2026: Grant or award of HURA derivative securities (Form 4, code A).
Dec 12, 2025: Grant or award of HURA derivative securities (Form 4, code A).
Nov 12, 2024: Grant or award of HURA derivative securities (Form 4, code A).
Oct 18, 2024: Grant or award of KTRA shares (Form 4, code A).

Other insiders filing for TuHURA Biosciences, Inc./NV (HURA)

Tendler Craig, Director
Ng George K, Director
MANUSO JAMES S J, Director
List Alan, Director
Hoffman Robert E., Director
Dearborn Dan, Chief Financial Officer

How to read Form 4 transaction codes